切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - CK1 - potassium channel - Angiotensin AT2 Receptors - Inward Rectifier Potassium (Kir) Channels

11件产品中的 1-10

页面
每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  4. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  5. PD123319
    B2206 PD123319
    Target: Angiotensin AT2 Receptors
    Summary: 血管紧张素AT2受体的拮抗剂
      ≥22.4 mg/mL
      ≥104.2 mg/mL
  6. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  7. PF-670462
    A3719 PF-670462
    Target: CK1
    Summary: CK1 ε/δ抑制剂
      ≥20.5 mg/mL
      ≥94 mg/mL
  8. PD 123319 ditrifluoroacetate
    A3704 PD 123319 ditrifluoroacetate
    Target: Angiotensin AT2 Receptors
    Summary: 血管紧张素AT2受体拮抗剂
      ≥110.2 mg/mL
      ≥73.7 mg/mL
  9. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O
  10. D4476
    A3342 D4476
     1 Citation
    Target: CK1
    Summary: CK1/ALK5抑制剂
      ≥19.9 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页